Abstract
Rosacea is a kind of common chronic inflammatory skin disease. According to clinical manifestations, rosacea can be divided into erythematous telangiectatic type, papulopustular type, hypertrophic type and ocular type. As the guideline of the American National Rosacea Society mentions, rosacea should be treated according to its subtypes. The treatment of rosacea mainly includes skin care, drugs, lasers, surgery, and so on. The development of new drugs, such as α-adrenergic receptor agonists, β-blockers and botulinum toxin-A targeting erythematous telangiectatic rosacea, and subantimicrobial-dose doxycycline and ivermectin targeting papulopustular rosacea, has brought possibilities to treat rosacea effectively. Owing to lack of experience in application of brimonidine tartrate, subantimicrobial-dose doxycycline and ivermectin, more evidence from clinical research is needed to evaluate their safety and efficacy. Key words: Rosacea; Rhinophyma; Chemistry, pharmaceutical; Therapeutic uses; Telangiectasis
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
